Skip to main content

Table 2 Adherence to treatment for the 11 children who completed the study

From: A pilot feasibility study of gabapentin for managing pain in children with dystonic cerebral palsy

  Days % treatment period
  Mean (SD) Mean (SD)
Total treatment period length in days 84 100%
Total days in which doses were taken (either according to protocol dosage or following adjustment by clinician or not specified) 56.3 (38.1) 67.0% (45.4%)
      According to protocol 33.6 (32.4) 40.0% (38.6%)
      Following adjustment by clinician 12.0 (15.7) 14.3% (18.7%)
      Dosage not specified 10.6 (19.7) 12.7% (23.5%)
Total days in which doses were missed (or dose not reported) 27.7 (38.1) 33.0% (45.4%)